SLCO1B1 c.521T>C (rs4149056) has been verified to be related to statin-induced myopathy risk, which is widely used to guide dose determination of statin drugs such as atorvastatin, pitavastatin, and simvastatin. The gene discussed is SLCO1B1; the disease is myopathy.